As melanoma evolves, it interacts with the immune system. Based on thi
s immunobiology, there are now a number of rationally designed attempt
s to develop genetically modified melanoma; vaccines. This article out
lines immunologic and other strategies in gene therapy for melanoma an
d provides an overview of current clinical trials.